Su ZT, Florissi IS, Geller AE, Johnson Iii BA, et al. Cost-Effectiveness of Perioperative Durvalumab With Neoadjuvant Gemcitabine/Cisplatin in Muscle-Invasive Bladder Cancer Treatment. J Natl Compr Canc Netw 2026 Mar 19:1-7. doi: 10.6004/jnccn.2025.7129.
PMID: 41911914